Literature DB >> 17853258

The changes of AgNOR parameters of anterior cingulate pyramidal neurons are region-specific in suicidal and non-suicidal depressive patients.

Tomasz Gos1, Dieter Krell, Ralf Brisch, Hendrik Bielau, Kurt Trübner, Hans-Gert Bernstein, Bernhard Bogerts.   

Abstract

The anterior cingulate cortex (AC) is consistently implicated in the pathophysiology of depression. While suicide has been shown in previous reports to be closely related to depression, it is still a distinct phenomenon. The aim to differentiate between depression and suicide was approached by the karyometric analysis of AC pyramidal neurons. The study was performed on paraffin-embedded brains from 20 depressive patients (10 of whom had committed suicide) and 24 matched controls. The karyometric parameters of the layer III and V pyramidal neurons of the dorsal and ventral AC were evaluated bilaterally by Argyrophilic Nucleolar Organiser (AgNOR) silver staining method. Control-specific was the increased nuclear area in ontogenetically younger pyramidal neurons layer III in the left dorsal compared with ventral AC (Wilcoxon test, P<0.01). The decreased AgNOR number per nucleus in these cells in the right ventral AC was depression-specific compared with controls (t-test, P=0.047). On the other hand, the diffuse decrease in AgNOR ratio throughout pyramidal neurons on the left side was specific for suicidal depressive patients compared with non-suicidal patients and controls (ANOVA, P=0.028). The results suggest that regionally differentiated depression- and suicide-specific disturbed function of the most important AC output cells exists in depressive patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853258     DOI: 10.1080/15622970601169758

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  5 in total

1.  Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil.

Authors:  Tomasz Gos; Johann Steiner; Hendrik Bielau; Henrik Dobrowolny; Karoline Günther; Christian Mawrin; Maciej Krzyżanowski; Roman Hauser; Ralf Brisch; Hans-Gert Bernstein; Zbigniew Jankowski; Katharina Braun; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-04-13       Impact factor: 5.270

2.  Ribosomal DNA transcription in prefrontal pyramidal neurons is decreased in suicide.

Authors:  Marta Krzyżanowska; Johann Steiner; Dorota Pieśniak; Karol Karnecki; Michał Kaliszan; Marek Wiergowski; Krzysztof Rębała; Ralf Brisch; Katharina Braun; Zbigniew Jankowski; Monika Kosmowska; Joanna Chociej; Tomasz Gos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-11       Impact factor: 5.270

3.  Reduced ribosomal DNA transcription in the prefrontal cortex of suicide victims: consistence of new molecular RT-qPCR findings with previous morphometric data from AgNOR-stained pyramidal neurons.

Authors:  Marta Krzyżanowska; Krzysztof Rębała; Johann Steiner; Michał Kaliszan; Dorota Pieśniak; Karol Karnecki; Marek Wiergowski; Ralf Brisch; Katharina Braun; Zbigniew Jankowski; Monika Kosmowska; Joanna Chociej; Tomasz Gos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-01-26       Impact factor: 5.270

4.  Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia.

Authors:  Marta Krzyżanowska; Johann Steiner; Ralf Brisch; Christian Mawrin; Stefan Busse; Katharina Braun; Zbigniew Jankowski; Hans-Gert Bernstein; Bernhard Bogerts; Tomasz Gos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-05       Impact factor: 5.270

5.  Decreased ribosomal DNA transcription in dorsal raphe nucleus neurons differentiates between suicidal and non-suicidal death.

Authors:  Marta Krzyżanowska; Johann Steiner; Karol Karnecki; Michał Kaliszan; Ralf Brisch; Marek Wiergowski; Katharina Braun; Zbigniew Jankowski; Tomasz Gos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-21       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.